Matteo Levisetti's most recent trade in Cue Biopharma Inc was a trade of 250,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on March 21, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Cue Biopharma Inc | Matteo Levisetti | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Mar 2025 | 250,000 | 250,000 | - | - | Stock Option (right to buy) | |
| Cue Biopharma Inc | Matteo Levisetti | Chief Medical Officer | 05 Jun 2024 | 125,000 | 125,000 | - | - | Stock Option (right to buy) | ||
| Cue Biopharma Inc | Matteo Levisetti | Chief Medical Officer | 06 Mar 2024 | 260,000 | 260,000 | - | - | Stock Option (right to buy) | ||
| Cue Biopharma Inc | Levisetti Matteo | Chief Medical Officer | 20 Feb 2024 | 25,000 | 25,000 | - | - | Stock Option (right to buy) | ||
| Cue Biopharma Inc | Matteo Levisetti | Chief Medical Officer | 21 Jul 2023 | 82,500 | 82,500 | - | - | Stock Option (right to buy) | ||
| Cue Biopharma Inc | Matteo Levisetti | Chief Medical Officer | 17 Jan 2023 | 110,000 | 110,000 | - | - | Stock Option (right to buy) |